Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Valiant Laboratories Ltd

NSE: VALIANTLAB · BSE: 543998 · Pharmaceuticals & Biotechnology · 24 announcements

Share price
₹124.25
Market cap
₹674.8 Cr
Revenue (annual)
₹237.5 Cr
Net profit (annual)
₹-3.27 Cr
P/E (TTM)
42.2×Sector 47.4×
Promoter holding
74.94%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

20:21 IST NSE
Financial Results

Valiant Laboratories Q1 FY27 Results: Net Profit ₹21.1 Cr, Up 1072.2% YoY

Valiant Laboratories Ltd reported revenue from operations of ₹115.3 Cr (+146.4% YoY) and net profit of ₹21.1 Cr (+1072.2% YoY) for Q1 FY27.

Key figure
Net profit ₹21.1 Cr · +1072.2% YoY
19:16 IST NSE
Financial Results

Valiant Laboratories Q4 FY26 Results: Net Profit ₹1.8 Cr, Up 157.1% YoY

Valiant Laboratories Ltd reported revenue from operations of ₹92 Cr (+59.2% YoY) and net profit of ₹1.8 Cr (+157.1% YoY) for Q4 FY26.

Key figure
Net profit ₹1.8 Cr · +157.1% YoY
19:15 IST NSE
Financial Results

Valiant Laboratories Financial Results

Valiant Laboratories approved audited standalone and consolidated financial results for fiscal year 2026. The board took on record an unmodified audit report from statutory auditors.